Works matching DE "SODIUM-glucose cotransporters"

Results: 1909

SGLT2 inhibitors reduce risk of serious renal events.

Published in:

Practitioner, 2020, v. 264, n. 1837, p. 8

By:

LOCKYER, MATTHEW

Publication type:

Article

Association between combined treatment with SGLT2 inhibitors and metformin for type 2 diabetes mellitus on fracture risk: a meta-analysis of randomized controlled trials.

Published in:

Osteoporosis International, 2020, v. 31, n. 12, p. 2313, doi. 10.1007/s00198-020-05590-y

By:

Qian, B-B.;
Chen, Q.;
Li, L.;
Yan, C-F.

Publication type:

Article

Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies.

Published in:

Osteoporosis International, 2019, v. 30, n. 10, p. 1923, doi. 10.1007/s00198-019-04968-x

By:

Hidayat, K.;
Du, X.;
Shi, B.-M.

Publication type:

Article

Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany-A retrospective analysis of real-world data.

Published in:

Osteoporosis International, 2017, v. 28, n. 8, p. 2421, doi. 10.1007/s00198-017-4051-y

By:

Dombrowski, S.;
Kostev, K.;
Jacob, L.

Publication type:

Article

Comparing the clinical outcomes across different sodium/glucose cotransporter 2 (SGLT2) inhibitors in heart failure patients: a systematic review and network meta-analysis of randomized controlled trials.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 10, p. 1453, doi. 10.1007/s00228-021-03147-4

By:

Teo, Yao Hao;
Yoong, Celine Shuen Yin;
Syn, Nicholas L.;
Teo, Yao Neng;
Cheong, Jia Yang Alex;
Lim, Yoke-Ching;
Lee, Chi-Hang;
Yeo, Tiong-Cheng;
Chai, Ping;
Wong, Raymond C. C.;
Lin, Weiqin;
Sia, Ching-Hui

Publication type:

Article

SGLT2 inhibitors and euglycemic diabetic ketoacidosis.

Published in:

2021

By:

Yousaf, Zohaib;
Ata, Fateen;
Khan, Adeel Ahmad;
Razok, Almurtada;
Akram, Jaweria;
Ali, Elrazi Awadelkarim Hamid;
Abdalhadi, Ahmed;
Danjuma, Mohammed I.;
Al Mohanadi, Dabia Hamad S. H.

Publication type:

Letter

Drug-drug interactions and inappropriate medicines impact on glycemic control and kidney function in older adults with diabetes-attending specialty care institution.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 9, p. 1397, doi. 10.1007/s00228-021-03107-y

By:

AL-Musawe, Labib;
Torre, Carla;
Guerreiro, Jose Pedro;
Rodrigues, Antonio Teixeira;
Raposo, Joao Filipe;
Mota-Filipe, Helder;
Martins, Ana Paula

Publication type:

Article

Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 5, p. 651, doi. 10.1007/s00228-020-03051-3

By:

Bamgboye, Adeboye Olakunle;
Oni, Isaac Oluwadamilare;
Collier, Andrew

Publication type:

Article

National trends in metformin-based combination therapy of oral hypoglycaemic agents for type 2 diabetes mellitus.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 12, p. 1723, doi. 10.1007/s00228-019-02751-9

By:

Kim, Jisu;
Park, Susin;
Kim, Hyunsoo;
Je, Nam Kyung

Publication type:

Article

Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes—cardiovascular and renal benefits in patients with chronic kidney disease.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 11, p. 1481, doi. 10.1007/s00228-019-02732-y

By:

Milder, Tamara Y.;
Stocker, Sophie L.;
Samocha-Bonet, Dorit;
Day, Richard O.;
Greenfield, Jerry R.

Publication type:

Article

Inhibition of sodium–glucose cotransporter-2 preserves cardiac function during regional myocardial ischemia independent of alterations in myocardial substrate utilization.

Published in:

Basic Research in Cardiology, 2019, v. 114, n. 3, p. N.PAG, doi. 10.1007/s00395-019-0733-2

By:

Baker, Hana E.;
Kiel, Alexander M.;
Luebbe, Samuel T.;
Simon, Blake R.;
Earl, Conner C.;
Regmi, Ajit;
Roell, William C.;
Mather, Kieren J.;
Tune, Johnathan D.;
Goodwill, Adam G.

Publication type:

Article

Long-Term Mortality and SGLT2 Inhibitors in Type 2 Diabetes with and without Renal Impairment: An Observational Cohort Study.

Published in:

Medical Principles & Practice, 2024, v. 33, n. 3, p. 251, doi. 10.1159/000537850

By:

Al-Muhaiteeb, Abdullah;
Alahmad, Barrak;
Abu-Farha, Mohamed;
Abubaker, Jehad;
Thanaraj, Thangavel A.;
Ali, Hamad;
Al-Mulla, Fahd;
Qaddoumi, Mohammad

Publication type:

Article

FLOW Trial: Semaglutide Lowers Risk for Major Kidney Disease, CV Events and Death Regardless of SGLT-2i Use.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

The SGLT2 inhibitor canagliflozin suppresses lipid synthesis and interleukin-1 beta in ApoE deficient mice.

Published in:

Biochemical Journal, 2020, v. 477, n. 12, p. 2347, doi. 10.1042/BCJ20200278

By:

Day, Emily A.;
Ford, Rebecca J.;
Lu, Jessie H.;
Lu, Rachel;
Lundenberg, Lucie;
Desjardins, Eric M.;
Green, Alex E.;
Lally, James S. V.;
Schertzer, Jonathan D.;
Steinberg, Gregory R.

Publication type:

Article

Effect of Sodium Glucose Co-transporter Type 2 Inhibitors on The Infract size among Diabetic Patients with ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Published in:

Zagazig University Medical Journal, 2024, v. 30, p. 336, doi. 10.21608/ZUMJ.2024.275740.3237

By:

Elkot, Moataz A.;
Ibrahim, Yasser Gaber;
Refaat, Refaat Mohamed;
Abomandour, Hala Gouda

Publication type:

Article

Low-dose sodium-glucose cotransporter 2 inhibitor ameliorates ischemic brain injury in mice through pericyte protection without glucose-lowering effects.

Published in:

Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03605-4

By:

Takashima, Masamitsu;
Nakamura, Kuniyuki;
Kiyohara, Takuya;
Wakisaka, Yoshinobu;
Hidaka, Masaoki;
Takaki, Hayato;
Yamanaka, Kei;
Shibahara, Tomoya;
Wakisaka, Masanori;
Ago, Tetsuro;
Kitazono, Takanari

Publication type:

Article

Prevalence of Admission Hyponatremia in Patients With Diabetes Treated With and Without an SGLT2 inhibitor.

Published in:

Journal of the Endocrine Society, 2023, v. 7, n. 4, p. 1, doi. 10.1210/jendso/bvad011

By:

Monnerat, Sophie;
Atila, Cihan;
Refardt, Julie;
Christ-Crain, Mirjam

Publication type:

Article

Erratum to: Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM.

Published in:: 2021
Publication type:: Correction Notice

CORRIGENDUM FOR "Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM".

Published in:: 2020
Publication type:: Correction Notice

SGLT2 inhibitors.

Published in:

SA Pharmaceutical Journal Incorporating Pharmacy Management, 2018, v. 85, n. 1, p. 72

By:

Steyn, Lynda

Publication type:

Article

Comparing the Effect of Dipeptidyl-Peptidase 4 Inhibitors and Sulfonylureas on Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Prospective Open-Label Study.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1715, doi. 10.3390/jcm8101715

By:

Cheng, Po-Chung;
Hsu, Shang-Ren;
Kuo, Jeng-Fu;
Cheng, Yun-Chung;
Liu, Yu-Hsiu;
Tu, Shih-Te

Publication type:

Article

Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 1, p. 45, doi. 10.3390/jcm8010045

By:

Milder, Tamara Y.;
Stocker, Sophie L.;
Abdel Shaheed, Christina;
McGrath-Cadell, Lucy;
Samocha-Bonet, Dorit;
Greenfield, Jerry R.;
Day, Richard O.

Publication type:

Article

Protective Effects of Ipragliflozin, a Sodium-glucose Cotransporter 2 Inhibitor, on a Non-alcoholic Steatohepatitis Mouse Model.

Published in:

Yonago Acta Medica, 2019, v. 62, n. 1, p. 30, doi. 10.33160/yam.2019.03.005

By:

Masafumi Yamane;
Tomomitsu Matono;
Jun-ichi Okano;
Ran Nagahara;
Yukako Matsuki;
Toshiaki Okamoto;
Ken-ichi Miyoshi;
Takaaki Sugihara;
Takakazu Nagahara;
Masahiko Koda;
Hajime Isomoto

Publication type:

Article

A systematic review of sodium-glucose cotransporter 2 inhibitors and renal profiles among Japanese patients with type 2 diabetes mellitus.

Published in:

Journal of Pharmaceutical Health Care & Sciences, 2023, v. 9, n. 1, p. 1, doi. 10.1186/s40780-023-00305-x

By:

Mukai, Junichi;
Okamura, Nakaba;
Saito, Yuki;
Kubota, Rie

Publication type:

Article

Evaluation of important human CYP450 isoforms and P‐glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktail.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2023, v. 132, n. 6, p. 487, doi. 10.1111/bcpt.13840

By:

Neyshaburinezhad, Navid;
Shirzad, Nooshin;
Rouini, Mohammadreza;
Namazi, Soha;
Khoshayand, Mohammadreza;
Esteghamati, Alireza;
Nakhjavani, Manouchehr;
Ghasim, Hengameh;
Gloor, Yvonne;
Daali, Youssef;
Ardakani, Yalda H.

Publication type:

Article

Sodium‐glucose co‐transporter‐2 inhibitors in heart failure with reduced ejection fraction: Current evidence and future perspectives.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2022, v. 131, n. 1, p. 5, doi. 10.1111/bcpt.13739

By:

Jensen, Jesper;
Omar, Massar;
Kistorp, Caroline;
Gustafsson, Finn;
Køber, Lars;
Møller, Jacob Eifer;
Schou, Morten

Publication type:

Article

In vivo antidiabetic activity of nimesulide due to inhibition of amino acid transport.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 1, p. 35, doi. 10.1111/bcpt.13670

By:

Joharapurkar, Amit;
Kshirsagar, Samadhan;
Patel, Vishal;
Patel, Maulik;
Savsani, Hardikkumar;
Jain, Mukul

Publication type:

Article

Doxazosin down‐regulates sodium‐glucose cotransporter‐2 and exerts a renoprotective effect in rat models of acute renal injury.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2020, v. 126, n. 5, p. 413, doi. 10.1111/bcpt.13371

By:

Rezq, Samar;
Nasr, Ahmed M.;
Shaheen, Aya;
Elshazly, Shimaa M.

Publication type:

Article

Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2016, v. 118, n. 2, p. 168, doi. 10.1111/bcpt.12457

By:

Storgaard, Heidi;
Bagger, Jonatan I.;
Knop, Filip K.;
Vilsbøll, Tina;
Rungby, Jørgen

Publication type:

Article

Impact of SGLT2i on cardiovascular outcomes and heart failure in patients with type 2 diabetes.

Published in:

AIMS Medical Science, 2018, v. 5, n. 1, p. 67, doi. 10.3934/medsci.2018.1.67

By:

Rodríguez, Juan José;
Ortega-Paz, Luis;
Brugaletta, Salvatore;
Sabaté, Manel

Publication type:

Article

Antihyperglycemic Effects of Salvia polystachya Cav. and Its Terpenoids: α-Glucosidase and SGLT1 Inhibitors.

Published in:

Plants (2223-7747), 2022, v. 11, n. 5, p. N.PAG, doi. 10.3390/plants11050575

By:

Ortega, Rocio;
Valdés, Miguel;
Alarcón-Aguilar, Francisco J.;
Fortis-Barrera, Ángeles;
Barbosa, Elizabeth;
Velazquez, Claudia;
Calzada, Fernando

Publication type:

Article

Discovery of UDP-Glycosyltransferases and BAHD-Acyltransferases Involved in the Biosynthesis of the Antidiabetic Plant Metabolite Montbretin A.

Published in:

Plant Cell, 2018, v. 30, n. 8, p. 1864, doi. 10.1105/tpc.18.00406

By:

Irmisch, Sandra;
Jo, Seohyun;
Roach, Christopher R.;
Jancsik, Sharon;
Yuen, Macaire Man Saint;
Madilao, Lufiani L.;
O'Neil-Johnson, Mark;
Williams, Russel;
Withers, Stephen G.;
Bohlmann, Joerg

Publication type:

Article

Research into glucose-lowering drugs for heart failure treatment.

Published in:

British Journal of Community Nursing, 2019, v. 24, n. 11, p. 560, doi. 10.12968/bjcn.2019.24.11.560

By:

Mendes, Aysha

Publication type:

Article

Combination of canagliflozin and puerarin alleviates the lipotoxicity to diabetic kidney in mice.

Published in:

Korean Journal of Physiology & Pharmacology, 2023, v. 27, n. 3, p. 221, doi. 10.4196/kjpp.2023.27.3.221

By:

Qian Zhu;
Qu Zhou;
Xiao-li Luo;
Xu-jie Zhang;
San-yu Li

Publication type:

Article

Pharmacological evaluation of HM41322, a novel SGLT1/2 dual inhibitor, in vitro and in vivo.

Published in:

Korean Journal of Physiology & Pharmacology, 2019, v. 23, n. 1, p. 55, doi. 10.4196/kjpp.2019.23.1.55

By:

Kyu Hang Lee;
Sang Don Lee;
Namdu Kim;
Kwee Hyun Suh;
Young Hoon Kim;
Sang Soo Sim

Publication type:

Article

SGLT2 Inhibitors: The Dawn of a New Era in Cardio-Metabolic Therapeutics.

Published in:

2022

By:

Deedwania, Prakash

Publication type:

Editorial

Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction.

Published in:

American Journal of Cardiovascular Drugs, 2021, v. 21, n. 6, p. 701, doi. 10.1007/s40256-021-00503-8

By:

Blair, Hannah A.

Publication type:

Article

Diabetes, Heart Failure and Beyond: Elucidating the Cardioprotective Mechanisms of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 1, p. 35, doi. 10.1007/s40256-021-00486-6

By:

Ojha, Utkarsh;
Reyes, Lenisse;
Eyenga, Florence;
Oumbe, Diane;
Watkowska, Justyna;
Saint-Jacques, Henock

Publication type:

Article

Comparative Efficacy of Five SGLT2i on Cardiorenal Events: A Network Meta-analysis Based on Ten CVOTs.

Published in:

American Journal of Cardiovascular Drugs, 2022, v. 22, n. 1, p. 69, doi. 10.1007/s40256-021-00484-8

By:

Qiu, Mei;
Ding, Liang-Liang;
Zhou, Hai-Rong

Publication type:

Article

Blood Pressure-Lowering Effect of Newer Antihyperglycemic Agents (SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors).

Published in:

American Journal of Cardiovascular Drugs, 2021, v. 21, n. 2, p. 123, doi. 10.1007/s40256-020-00423-z

By:

Liakos, Charalampos I.;
Papadopoulos, Dimitrios P.;
Sanidas, Elias A.;
Markou, Maria I.;
Hatziagelaki, Erifili E.;
Grassos, Charalampos A.;
Velliou, Maria L.;
Barbetseas, John D.

Publication type:

Article

Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention.

Published in:

American Journal of Cardiovascular Drugs, 2020, v. 20, n. 5, p. 419, doi. 10.1007/s40256-020-00397-y

By:

Reid, Jessica;
Rana, Khyatiben;
Niman, Stephanie;
Sheikh-Ali, Mae;
Lewis, Todd;
Choksi, Rushab R.;
Goldfaden, Rebecca F.

Publication type:

Article

Cardiovascular Protection with Anti-hyperglycemic Agents.

Published in:

American Journal of Cardiovascular Drugs, 2019, v. 19, n. 3, p. 249, doi. 10.1007/s40256-019-00325-9

By:

Deedwania, Prakash;
Acharya, Tushar

Publication type:

Article

Effect of Insulin on Proximal Tubules Handling of Glucose: A Systematic Review.

Published in:

Journal of Diabetes Research, 2020, p. 1, doi. 10.1155/2020/8492467

By:

Pereira-Moreira, Ricardo;
Muscelli, Elza

Publication type:

Article

How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area.

Published in:

Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/2018374

By:

Canivell, Silvia;
Mata-Cases, Manel;
Vlacho, Bogdan;
Gratacòs, Mònica;
Real, Jordi;
Mauricio, Dídac;
Franch-Nadal, Josep

Publication type:

Article

Analysis of SGLT2 Inhibitor Therapy and Other Potential Risk Factors for the Development of Bacteremia in Patients With Urosepsis.

Published in:

Journal of Pharmacy Technology, 2022, v. 38, n. 2, p. 67, doi. 10.1177/87551225221074578

By:

Covington, Elizabeth W.;
Slaten, Kelly;
Harnden, Adam

Publication type:

Article

Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease—Current Background, Hopes, and Perspectives.

Published in:

Metabolites (2218-1989), 2023, v. 13, n. 5, p. 581, doi. 10.3390/metabo13050581

By:

Cazac, Georgiana-Diana;
Lăcătușu, Cristina-Mihaela;
Ștefănescu, Gabriela;
Mihai, Cătălina;
Grigorescu, Elena-Daniela;
Onofriescu, Alina;
Mihai, Bogdan-Mircea

Publication type:

Article

The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis.

Published in:

Metabolites (2218-1989), 2022, v. 12, n. 10, p. 979, doi. 10.3390/metabo12100979

By:

Xu, Chunmei;
He, Liping;
Zhang, Jing;
Xu, Lusi;
Dong, Jianjun;
Liao, Lin

Publication type:

Article

Effects of Arachidonic Acid and Its Metabolites on Functional Beta-Cell Mass.

Published in:

Metabolites (2218-1989), 2022, v. 12, n. 4, p. N.PAG, doi. 10.3390/metabo12040342

By:

Bosma, Karin J.;
Kaiser, Cecilia E.;
Kimple, Michelle E.;
Gannon, Maureen

Publication type:

Article

Sodium-Glucose Cotransporter-2 Inhibitors Improve Cardiovascular Dysfunction in Type 2 Diabetic East Asians.

Published in:

Metabolites (2218-1989), 2021, v. 11, n. 11, p. 794, doi. 10.3390/metabo11110794

By:

Afzal, Muhammad;
Al-Abbasi, Fahad A.;
Nadeem, Muhammad Shahid;
Alshehri, Sultan;
Ghoneim, Mohammed M.;
Imam, Syed Sarim;
Almalki, Waleed Hassan;
Kazmi, Imran

Publication type:

Article

The Effects of SGLT2 Inhibitors on Lipid Metabolism.

Published in:

Metabolites (2218-1989), 2021, v. 11, n. 2, p. 87, doi. 10.3390/metabo11020087

By:

Szekeres, Zsolt;
Toth, Kalman;
Szabados, Eszter

Publication type:

Article